Company intelligence / Profile preview

Pharma in Silica

Quebec City, Quebec, Canadapharma-insilica.com ↗
Ownership
Private
Development stage
Other
01

Overview

The company has completed preclinical development and pre-regulatory meetings with the FDA and Health Canada. Its lead program OpPacli™, a patented nano-sized silica carrier for paclitaxel chemotherapy targeting solid tumors such as NSCLC, aims to improve efficacy and reduce toxicity. As of October 2024, the company secured $4M investment to prepare for North American clinical trials. No human clinical results yet.

Therapeutic areas
Oncology
Modalities
Nanomedicinenanoparticle drug delivery (specifically nano-sized silica spheres)cytotoxic drugs (e.g., paclitaxel)
Industry
Biotech
02

Drug pipeline

4 assets

OpCombo

Preclinical

3 more assets in the full pipeline.

Request access →
03

Partnerships

Collaborates with oncology experts and world-renowned research centers; seeking licensing partnerships with major pharmaceutical companies post-clinical proof-of-concept.

Beyond the preview

Go deeper on Pharma in Silica.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pharma in Silica.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call